Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
BT-20 | 0 | uM | 4 | 312.50 | 138.79 | 223.00 | 285.25 | 0.7818 | 0.5782 | |
BT-20 | Taxol | 0.00033113 | uM | 4 | 312.50 | 138.79 | 220.00 | 285.25 | 0.7713 | 0.5577 |
BT-20 | Methotrexate | 0.01 | uM | 4 | 312.50 | 138.79 | 250.00 | 285.25 | 0.8764 | 0.7616 |
BT-20 | Omipalisib | 1 | uM | 4 | 312.50 | 138.79 | 68.00 | 285.25 | 0.2384 | -0.4967 |
BT-20 | Methotrexate | 10 | uM | 4 | 312.50 | 138.79 | 297.00 | 285.25 | 1.0412 | 1.0792 |
BT-20 | Palbociclib | 1 | uM | 4 | 312.50 | 138.79 | 185.00 | 285.25 | 0.6486 | 0.3185 |
BT-20 | Methotrexate | 0.31623 | uM | 4 | 312.50 | 138.79 | 194.00 | 285.25 | 0.6801 | 0.3802 |
BT-20 | Taxol | 0.0031623 | uM | 4 | 312.50 | 138.79 | 200.00 | 285.25 | 0.7011 | 0.4212 |
BT-20 | Methotrexate | 0.1 | uM | 4 | 312.50 | 138.79 | 374.00 | 285.25 | 1.3111 | 1.5955 |
BT-20 | Omipalisib | 0.31623 | uM | 4 | 312.50 | 138.79 | 80.00 | 285.25 | 0.2805 | -0.4115 |
BT-20 | 0 | uM | 4 | 312.50 | 138.79 | 448.00 | 285.25 | 1.5706 | 2.0879 | |
BT-20 | Palbociclib | 0.31623 | uM | 4 | 312.50 | 138.79 | 171.00 | 285.25 | 0.5995 | 0.2224 |
BT-20 | Omipalisib | 0.01 | uM | 4 | 312.50 | 138.79 | 199.00 | 285.25 | 0.6976 | 0.4144 |
BT-20 | 0 | uM | 4 | 312.50 | 138.79 | 363.00 | 285.25 | 1.2726 | 1.5220 | |
BT-20 | Omipalisib | 0.0033113 | uM | 4 | 312.50 | 138.79 | 285.00 | 285.25 | 0.9991 | 0.9983 |
BT-20 | Taxol | 0.1 | uM | 4 | 312.50 | 138.79 | 124.00 | 285.25 | 0.4347 | -0.1028 |
BT-20 | Taxol | 0.001 | uM | 4 | 312.50 | 138.79 | 280.00 | 285.25 | 0.9816 | 0.9646 |
BT-20 | Palbociclib | 3.1623 | uM | 4 | 312.50 | 138.79 | 142.00 | 285.25 | 0.4978 | 0.0222 |
BT-20 | Palbociclib | 0.031623 | uM | 4 | 312.50 | 138.79 | 225.00 | 285.25 | 0.7888 | 0.5918 |
BT-20 | Palbociclib | 19.9526 | uM | 4 | 312.50 | 138.79 | 126.00 | 285.25 | 0.4417 | -0.0888 |
BT-20 | Omipalisib | 10 | uM | 4 | 312.50 | 138.79 | 37.00 | 285.25 | 0.1297 | -0.7198 |
BT-20 | 0 | uM | 4 | 312.50 | 138.79 | 236.00 | 285.25 | 0.8273 | 0.6666 | |
BT-20 | 0 | uM | 4 | 312.50 | 138.79 | 235.00 | 285.25 | 0.8238 | 0.6598 | |
BT-20 | 0 | uM | 4 | 625.00 | 288.04 | 661.00 | 740.75 | 0.8923 | 0.8396 | |
BT-20 | 0 | uM | 4 | 625.00 | 288.04 | 648.00 | 740.75 | 0.8748 | 0.8130 |